Evidence map›Paper›PMID 32046739›Full record

ArticleMalaria journal2020

Rapid phenotyping towards personalized malaria medicine.

Maria Isabel Veiga, Weng Kung Peng

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. A Brief Review on Medicinal Plants-At-Arms against COVID-19.Interdisciplinary perspectives on infectious diseases · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Multi-Omics Advancements towardsDiagnostics (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Maria Isabel VeigaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Weng Kung PengPrecision Medicine-Engineering Group, International Iberian Nanotechnology Laboratory, Braga, Portugal. weng.kung@inl.int.ORCID http://orcid.org/0000-0002-7984-9319
International Iberian Nanotechnology Laboratory · PTUniversity of Minho · PT

Funding

Norte 2020 NORTE-01-0145-FEDER-000013
6 · The paper itself

Abstract

Malaria is major public health concerns which continues to claim the lives of more than 435,000 people each year. The challenges with anti-malarial drug resistance and detection of low parasitaemia forms an immediate barrier to achieve the fast-approaching United Nations Sustainable Development Goals of ending malaria epidemics by 2030. In this Opinion article, focusing on the recent published technologies, in particularly the nuclear magnetic resonance (NMR)-based diagnostic technologies, the authors offer their perspectives and highlight ways to bring these point-of-care technologies towards personalized medicine. To this end, they advocate an open sourcing initiative to rapidly close the gap between technological innovations and field implementation.

Indexed as

Point-of-Care TestingAnimalsDrug ResistanceHemeproteinsHumansMagnetic Resonance SpectroscopyMalariaPhenotypePlasmodiumPrecision MedicineSensitivity and SpecificityHemeproteinshemozoinMalaria control and eliminationPersonalized medicineTechnological innovations

Identifiers

PMID32046739
PMCPMC7014641
OpenAlexW3006005826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.